Embodied Access and the Formation of Clinical Attention
Philosophy & Technology · 2026-12 · 39 (4)
DOI: 10.1007/s13347-026-01244-9 ↗Kurz gefasst
Fachartikel in der Zeitschrift Philosophy & Technology, online erschienen am 20.11.2026. Verfasst von Philipp Kellmeyer. Die Arbeit nennt 4 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Universitätsklinikum Freiburg.
Abstract (Originalsprache)
Michelle Charette’s account of presence as embodied access provides a valuable framework for examining how clinical virtual reality structures opportunities for perception, action, and interaction. This commentary draws on cognitive science, psychology, and neurology, focusing on the hypothesis that repeated virtual encounters may influence clinical attention and conduct. Three proposed experiments would distinguish the effects of visual realism and tactile contact, examine responses to contingent patient behavior, and assess transfer to standardized patient encounters outside virtual reality. Qualitative descriptions would complement behavioral measures to characterize how trainees experience these environments. Considering trainees’ sensory capacities and patients’ communication needs extends the framework to accessible training and responsive care. The commentary proposes evaluating simulations through the clinical orientations they enable learners to practice and potentially carry into patient care.
Förderung
- Universitätsklinikum Freiburg
Zitieren
APA
Kellmeyer, P. (2026). Embodied Access and the Formation of Clinical Attention. Philosophy & Technology, 39(4). https://doi.org/10.1007/s13347-026-01244-9
Vancouver
Kellmeyer P. Embodied Access and the Formation of Clinical Attention. Philosophy & Technology. 2026;39(4). doi:10.1007/s13347-026-01244-9
BibTeX
@article{Kellmeyer2026,
author = {Kellmeyer, Philipp},
title = {Embodied Access and the Formation of Clinical Attention},
journal = {Philosophy & Technology},
year = {2026},
volume = {39},
number = {4},
doi = {10.1007/s13347-026-01244-9}
}
EUVIMED